Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Bayer tests novel thrombin inhibitor BAY-224 in thrombosis models

July 14, 2017

Vifor Pharma begins three studies in iron deficiency and heart failure

July 14, 2017

Shire develops enhanced factor IX gene therapy

July 13, 2017

First-in-human study finds TFPI inhibitor PF-06741086 well tolerated

July 12, 2017

MedigenixBio tests new antithrombotic compound MDI-2001 in vivo

July 12, 2017

Global Blood Therapeutics expands phase IIa study of GBT-440

July 11, 2017

FDA approves Endari for sickle cell disease

July 10, 2017

Alnylam and Sanofi Genzyme initiate ATLAS phase III program for fitusiran

July 10, 2017

Shire applies for approval of icatibant in Japan

July 7, 2017

Shire submits IND to FDA for SHP-654 as treatment of hemophilia A

July 7, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...